Sun Pharmaceutical Industries share price
You have to be logged in to add this to Watchlist.- ₹1,664.70(-0.03%)April 22, 2026 14:13:01 PM IST
- NSE
- BSE
- Vol : 1.37 M (NSE + BSE)Last 20 day avg : 3.32 M
Sun Pharmaceutical Industries is trading -0.03% lower at Rs 1,664.70 as compared to its last closing price. Sun Pharmaceutical Industries has been trading in the price range of 1,671.10 & 1,652.50. Sun Pharmaceutical Industries has given -3.17% in this year & 0.79% in the last 5 days. Sun Pharmaceutical Industries has TTM P/E ratio 39.35 as compared to the sector P/E of 26.46.There are 36 analysts who have initiated coverage on Sun Pharmaceutical Industries. There are 13 analysts who have given it a strong buy rating & 19 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 3,368.81 Crores in its last quarter.Listed peers of Sun Pharmaceutical Industries include Divi's Laboratories (0.04%), Dr Reddy's Laboratories (-0.01%), Cipla (0.21%).The Mutual Fund holding in Sun Pharmaceutical Industries was at 11.96% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Sun Pharmaceutical Industries was at 15.94% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 22, 2026, 08:43 AM UTC
- BetaLow volatility0.63Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldInline with the industry0.99Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.74The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Moderately Bullish | 6,287.95 | 0.04 | 1,66,939.92 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bearish | 1,220.65 | -0.01 | 1,01,940.26 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Neutral | 1,235.50 | 0.21 | 99,825.83 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Neutral | 4,096.55 | -0.90 | 1,39,109.72 | 67.32 | 17.1 | 0.83 | 17.62 |
| Lupin | Neutral | 2,302.00 | -0.42 | 1,05,550.82 | 28.78 | 5.59 | 0.57 | 11.80 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-31 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results & Interim Dividend |
- IndustryBiotechnology & Drugs
- ISININE044A01036
- BSE Code524715
- NSE CodeSUNPHARMA
Sun Pharmaceutical Industries is trading at 1664.70 as on Wed Apr 22 2026 08:43:01. This is -0.03% lower as compared to its previous closing price of 1665.25.
The market capitalization of Sun Pharmaceutical Industries is 399299.98 Cr as on Wed Apr 22 2026 08:43:01.
The average broker rating on Sun Pharmaceutical Industries is Buy. The breakup of analyst rating is given below -
- 13 analysts have given a strong buy rating
- 19 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 3 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Sun Pharmaceutical Industries is 1850.95 whereas the 52 wk low is 1547.25
Sun Pharmaceutical Industries can be analyzed on the following key metrics -
- TTM P/E: 39.35
- Sector P/E: 26.46
- Dividend Yield: 0.99%
- D/E ratio: -
Sun Pharmaceutical Industries reported a net profit of 10929.04 Cr in 2025.
The Mutual Fund Shareholding was 11.96% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Sun Pharmaceutical Industries QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.